Reuters logo
BRIEF-Editas Medicine Inc initiates clinical natural history study of Leber Congenital Amaurosis type 10
September 12, 2017 / 1:23 PM / 10 days ago

BRIEF-Editas Medicine Inc initiates clinical natural history study of Leber Congenital Amaurosis type 10

Sept 12 (Reuters) - Editas Medicine Inc

* Editas Medicine Inc - announced that company initiated a clinical natural history study of Leber Congenital Amaurosis type 10 (LCA10)

* Editas Medicine Inc - Editas medicine plans to submit an Investigational New Drug (IND) application for EDIT-101 in mid-2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below